NBBTF.US Natural Beauty Bio-Technology Limited
- Market cap
- USD 100M
- P/E
- -
- P/B
- 1.85x
- ROE
- -54.0%
- Dividend yield
- -
- Fundamental score
- -
Ratios use the latest price and the current fiscal year annualized from 1 quarter up to Jun 2026.
Is NBBTF.US undervalued?
Graham numberThe Graham number of Natural Beauty Bio-Technology Limited cannot be estimated reliably (it needs positive earnings and book value).
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
Natural Beauty Bio-Technology Limited fundamental analysis
No fundamental analysis for Natural Beauty Bio-Technology Limited yet.
Natural Beauty Bio-Technology Limited stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About Natural Beauty Bio-Technology Limited
Natural Beauty Bio-Technology Limited, an investment holding company, provides skin care products and services in Mainland China, Taiwan, and internationally. It manufactures and sells skin care, beauty, aroma-therapeutic, and make-up products, as well as health supplements under the Natural Beauty brand. The company also offers skin treatments, beauty and spa services, medical cosmetology services, and skin care consulting and beauty training services, as well as beauty app…
Full company profileNatural Beauty Bio-Technology Limited financial statements
2026 annualized: Fiscal year 2026 is not finished. Income statement and cash flow are annualized from 1 quarter up to Jun 30, 2026, the balance sheet is the latest quarter. Figures change when the annual report is published.
Natural Beauty Bio-Technology Limited annual financial statements
| Item | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 Anlz |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Income Statement | |||||||||||
| Revenue | 475M | 400M | 370M | 438M | 411M | 488M | 336M | 336M | 354M | 539M | 996M |
| Gross Profit | 353M | 305M | 223M | 248M | 217M | 282M | 165M | 200M | 202M | 269M | 324M |
| Operating Income | 163M | 138M | 37.3M | 39.1M | 4.31M | 50.5M | -19.2M | -3.74M | -97.2M | 17.7M | -210M |
| EBITDA | 185M | 158M | 61.7M | 69.2M | 47.4M | 85.2M | 15.1M | 22.9M | -65.5M | 56.5M | -86.1M |
| Net Income | 148M | 105M | 26.3M | 21.9M | 7.76M | 35.3M | -30.5M | -15.1M | -104M | 10.6M | -228M |
| EPS | 0.07 | 0.05 | 0.01 | 0.01 | 0.00 | 0.02 | -0.02 | -0.01 | -0.05 | 0.01 | -0.11 |
| Balance Sheet | |||||||||||
| Total Assets | 822M | 778M | 679M | 768M | 841M | 937M | 884M | 883M | 773M | 931M | 1.01B |
| Total Liabilities | 168M | 127M | 127M | 200M | 230M | 279M | 286M | 308M | 325M | 457M | 587M |
| Shareholders' Equity | 655M | 651M | 552M | 568M | 611M | 658M | 597M | 575M | 448M | 474M | 423M |
| Cash & Short-term Investments | 429M | 289M | 181M | 149M | 166M | 197M | 169M | 167M | 117M | 112M | 116M |
| Total Debt | - | - | - | 52.9M | 75.0M | 129M | 143M | 186M | 212M | 319M | 425M |
| Cash Flow | |||||||||||
| Operating Cash Flow | 128M | 21.2M | 74.0M | 20.3M | 30.1M | 42.8M | 11.6M | 21.7M | -13.7M | -25.7M | -197M |
| Capital Expenditure | 19.0M | 32.3M | 51.8M | 76.4M | 73.9M | 38.1M | 44.3M | 69.1M | 41.2M | 68.2M | 136M |
| Free Cash Flow | 109M | -11.1M | 22.2M | -56.1M | -43.8M | 4.67M | -36.0M | -47.4M | -55.0M | -93.9M | -333M |
| Ratios | |||||||||||
| ROE | 22.7% | 16.2% | 4.8% | 3.9% | 1.3% | 5.4% | -5.1% | -2.6% | -23.1% | 2.2% | -54.0% |
| ROA | 18.0% | 13.5% | 3.9% | 2.9% | 0.9% | 3.8% | -3.4% | -1.7% | -13.4% | 1.1% | -22.6% |
| Net Profit Margin | 31.2% | 26.4% | 7.1% | 5.0% | 1.9% | 7.2% | -9.1% | -4.5% | -29.3% | 2.0% | -22.9% |
| Debt to Equity | - | - | - | 0.09x | 0.12x | 0.20x | 0.24x | 0.32x | 0.47x | 0.67x | 1.00x |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Total Debt
- Short and long-term borrowings.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
- Debt to Equity
- Total debt divided by shareholders' equity.
Natural Beauty Bio-Technology Limited dividends
- Dividend yield
- -
- Forward dividend
- -
- Payout ratio
- -
- Ex-dividend date
- Jun 1, 2022
| Fiscal year | Dividends paid | Per share | Payout ratio |
|---|---|---|---|
| 2025 | - | - | - |
| 2024 | - | - | - |
| 2023 | - | - | - |
| 2022 | USD 6.01M | 0.00 | - |
| 2021 | USD 6.01M | 0.00 | 17.0% |
| 2020 | USD 6.01M | 0.00 | 77.4% |
| 2019 | USD 6.01M | 0.00 | 27.4% |
| 2018 | HKD 96.1M | 0.05 | 366.0% |
| 2017 | HKD 161M | 0.08 | 152.4% |
From the cash flow statement: dividends paid in the fiscal year, divided by that year's shares outstanding. Payout ratio = dividends paid / net income.
Who owns Natural Beauty Bio-Technology Limited
- Insiders 75.00%
- Institutions 0.00%
- Public & others 25.00%
- Shares outstanding 2.00B
- Free float 501M
Natural Beauty Bio-Technology Limited company profile
- Company name
- Natural Beauty Bio-Technology Limited
- Ticker
- NBBTF.US
- Exchange
- USA Stocks
- Sector
- Consumer Defensive
- Industry
- Personal Care Products
- Employees
- 597
- Fiscal year end
- December
- Address
- Lee Garden One, Causeway Bay, Hong Kong
- Phone
- 852 4008 202 202
About Natural Beauty Bio-Technology Limited
Natural Beauty Bio-Technology Limited, an investment holding company, provides skin care products and services in Mainland China, Taiwan, and internationally. It manufactures and sells skin care, beauty, aroma-therapeutic, and make-up products, as well as health supplements under the Natural Beauty brand. The company also offers skin treatments, beauty and spa services, medical cosmetology services, and skin care consulting and beauty training services, as well as beauty apparatus. In addition, its spas provide hydrotherapy, facial treatment, body care, and skin care analysis services. Further, the company engages in the wholesale of skin care and beauty products. Natural Beauty Bio-Technology Limited was founded in 1976 and is based in Causeway Bay, Hong Kong.
Natural Beauty Bio-Technology Limited management
6- Dr. Chien LeiExecutive Chairperson · born 1959
- Mr. Chi Chung ChengChief Executive Officer · born 1966
- Ms. Yen-Ling LinExecutive Director · born 1964
- Dr. Yen-Yu TsaiFounder & Honorary Chairman · born 1948
- Ms. Jenny ZhuChief Legal Counsel
- Ms. Mei Yi Lee ACIS, ACS, FCIS, FCSCompany Secretary · born 1968